{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T22:52:36Z","timestamp":1794610356087,"version":"4.9.1"},"reference-count":38,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCO"],"published-print":{"date-parts":[[2012,3,10]]},"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p> Adult T-cell leukemia-lymphoma (ATL) is usually resistant to conventional chemotherapies, and there are few other treatment options. Because CC chemokine receptor 4 (CCR4) is expressed on tumor cells from most patients with ATL, KW-0761, a humanized anti-CCR4 monoclonal antibody, which markedly enhances antibody-dependent cellular cytotoxicity, was evaluated in the treatment of patients with relapsed ATL. <\/jats:p><\/jats:sec><jats:sec><jats:title>Patients and Methods<\/jats:title><jats:p> A multicenter phase II study of KW-0761 for patients with relapsed, aggressive CCR4-positive ATL was conducted to evaluate efficacy, pharmacokinetic profile, and safety. The primary end point was overall response rate, and secondary end points included progression-free and overall survival from the first dose of KW-0761. Patients received intravenous infusions of KW-0761 once per week for 8 weeks at a dose of 1.0 mg\/kg. <\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p> Of 28 patients enrolled onto the study, 27 received at least one infusion of KW-0761. Objective responses were noted in 13 of 26 evaluable patients, including eight complete responses, with an overall response rate of 50% (95% CI, 30% to 70%). Median progression-free and overall survival were 5.2 and 13.7 months, respectively. The mean half-life period after the eighth infusion was 422 \u00b1 147 hours (\u00b1 standard deviation). The most common adverse events were infusion reactions (89%) and skin rashes (63%), which were manageable and reversible in all cases. <\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p> KW-0761 demonstrated clinically meaningful antitumor activity in patients with relapsed ATL, with an acceptable toxicity profile. Further investigation of KW-0761 for treatment of ATL and other T-cell neoplasms is warranted. <\/jats:p><\/jats:sec>","DOI":"10.1200\/jco.2011.37.3472","type":"journal-article","created":{"date-parts":[[2012,2,7]],"date-time":"2012-02-07T08:29:54Z","timestamp":1328603394000},"page":"837-842","source":"Crossref","is-referenced-by-count":600,"title":["Defucosylated Anti-CCR4 Monoclonal Antibody (KW-0761) for Relapsed Adult T-Cell Leukemia-Lymphoma: A Multicenter Phase II Study"],"prefix":"10.1200","volume":"30","author":[{"given":"Takashi","family":"Ishida","sequence":"first","affiliation":[{"name":"Takashi Ishida, Hiroshi Inagaki, and Ryuzo Ueda, Nagoya City University Graduate School of Medical Sciences; Kazuhito Yamamoto, Aichi Cancer Center; Michinori Ogura, Nagoya Daini Red Cross Hospital, Nagoya; Tatsuro Joh and Masao Tomonaga, Japanese Red Cross Nagasaki Genbaku Hospital; Shinichiro Yoshida, Nagasaki Medical Center; Kunihiro Tsukasaki, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Science, Nagasaki; Naokuni Uike, National Kyushu Cancer Center; Toshihiro..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuro","family":"Joh","sequence":"additional","affiliation":[{"name":"Takashi Ishida, Hiroshi Inagaki, and Ryuzo Ueda, Nagoya City University Graduate School of Medical Sciences; Kazuhito Yamamoto, Aichi Cancer Center; Michinori Ogura, Nagoya Daini Red Cross Hospital, Nagoya; Tatsuro Joh and Masao Tomonaga, Japanese Red Cross Nagasaki Genbaku Hospital; Shinichiro Yoshida, Nagasaki Medical Center; Kunihiro Tsukasaki, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Science, Nagasaki; Naokuni Uike, National Kyushu Cancer Center; Toshihiro..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naokuni","family":"Uike","sequence":"additional","affiliation":[{"name":"Takashi Ishida, Hiroshi Inagaki, and Ryuzo Ueda, Nagoya City University Graduate School of Medical Sciences; Kazuhito Yamamoto, Aichi Cancer Center; Michinori Ogura, Nagoya Daini Red Cross Hospital, Nagoya; Tatsuro Joh and Masao Tomonaga, Japanese Red Cross Nagasaki Genbaku Hospital; Shinichiro Yoshida, Nagasaki Medical Center; Kunihiro Tsukasaki, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Science, Nagasaki; Naokuni Uike, National Kyushu Cancer Center; Toshihiro..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhito","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Takashi Ishida, Hiroshi Inagaki, and Ryuzo Ueda, Nagoya City University Graduate School of Medical Sciences; Kazuhito Yamamoto, Aichi Cancer Center; Michinori Ogura, Nagoya Daini Red Cross Hospital, Nagoya; Tatsuro Joh and Masao Tomonaga, Japanese Red Cross Nagasaki Genbaku Hospital; Shinichiro Yoshida, Nagasaki Medical Center; Kunihiro Tsukasaki, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Science, Nagasaki; Naokuni Uike, National Kyushu Cancer Center; Toshihiro..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atae","family":"Utsunomiya","sequence":"additional","affiliation":[{"name":"Takashi Ishida, Hiroshi Inagaki, and Ryuzo Ueda, Nagoya City University Graduate School of Medical Sciences; Kazuhito Yamamoto, Aichi Cancer Center; Michinori Ogura, Nagoya Daini Red Cross Hospital, Nagoya; Tatsuro Joh and Masao Tomonaga, Japanese Red Cross Nagasaki Genbaku Hospital; Shinichiro Yoshida, Nagasaki Medical Center; Kunihiro Tsukasaki, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Science, Nagasaki; Naokuni Uike, National Kyushu Cancer Center; Toshihiro..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichiro","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Takashi Ishida, Hiroshi Inagaki, and Ryuzo Ueda, Nagoya City University Graduate School of Medical Sciences; Kazuhito Yamamoto, Aichi Cancer Center; Michinori Ogura, Nagoya Daini Red Cross Hospital, Nagoya; Tatsuro Joh and Masao Tomonaga, Japanese Red Cross Nagasaki Genbaku Hospital; Shinichiro Yoshida, Nagasaki Medical Center; Kunihiro Tsukasaki, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Science, Nagasaki; Naokuni Uike, National Kyushu Cancer Center; Toshihiro..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Saburi","sequence":"additional","affiliation":[{"name":"Takashi Ishida, Hiroshi Inagaki, and Ryuzo Ueda, Nagoya City University Graduate School of Medical Sciences; Kazuhito Yamamoto, Aichi Cancer Center; Michinori Ogura, Nagoya Daini Red Cross Hospital, Nagoya; Tatsuro Joh and Masao Tomonaga, Japanese Red Cross Nagasaki Genbaku Hospital; Shinichiro Yoshida, Nagasaki Medical Center; Kunihiro Tsukasaki, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Science, Nagasaki; Naokuni Uike, National Kyushu Cancer Center; Toshihiro..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Miyamoto","sequence":"additional","affiliation":[{"name":"Takashi Ishida, Hiroshi Inagaki, and Ryuzo Ueda, Nagoya City University Graduate School of Medical Sciences; Kazuhito Yamamoto, Aichi Cancer Center; Michinori Ogura, Nagoya Daini Red Cross Hospital, Nagoya; Tatsuro Joh and Masao Tomonaga, Japanese Red Cross Nagasaki Genbaku Hospital; Shinichiro Yoshida, Nagasaki Medical Center; Kunihiro Tsukasaki, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Science, Nagasaki; Naokuni Uike, National Kyushu Cancer Center; Toshihiro..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeki","family":"Takemoto","sequence":"additional","affiliation":[{"name":"Takashi Ishida, Hiroshi Inagaki, and Ryuzo Ueda, Nagoya City University Graduate School of Medical Sciences; Kazuhito Yamamoto, Aichi Cancer Center; Michinori Ogura, Nagoya Daini Red Cross Hospital, Nagoya; Tatsuro Joh and Masao Tomonaga, Japanese Red Cross Nagasaki Genbaku Hospital; Shinichiro Yoshida, Nagasaki Medical Center; Kunihiro Tsukasaki, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Science, Nagasaki; Naokuni Uike, National Kyushu Cancer Center; Toshihiro..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Suzushima","sequence":"additional","affiliation":[{"name":"Takashi Ishida, Hiroshi Inagaki, and Ryuzo Ueda, Nagoya City University Graduate School of Medical Sciences; Kazuhito Yamamoto, Aichi Cancer Center; Michinori Ogura, Nagoya Daini Red Cross Hospital, Nagoya; Tatsuro Joh and Masao Tomonaga, Japanese Red Cross Nagasaki Genbaku Hospital; Shinichiro Yoshida, Nagasaki Medical Center; Kunihiro Tsukasaki, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Science, Nagasaki; Naokuni Uike, National Kyushu Cancer Center; Toshihiro..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunihiro","family":"Tsukasaki","sequence":"additional","affiliation":[{"name":"Takashi Ishida, Hiroshi Inagaki, and Ryuzo Ueda, Nagoya City University Graduate School of Medical Sciences; Kazuhito Yamamoto, Aichi Cancer Center; Michinori Ogura, Nagoya Daini Red Cross Hospital, Nagoya; Tatsuro Joh and Masao Tomonaga, Japanese Red Cross Nagasaki Genbaku Hospital; Shinichiro Yoshida, Nagasaki Medical Center; Kunihiro Tsukasaki, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Science, Nagasaki; Naokuni Uike, National Kyushu Cancer Center; Toshihiro..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kisato","family":"Nosaka","sequence":"additional","affiliation":[{"name":"Takashi Ishida, Hiroshi Inagaki, and Ryuzo Ueda, Nagoya City University Graduate School of Medical Sciences; Kazuhito Yamamoto, Aichi Cancer Center; Michinori Ogura, Nagoya Daini Red Cross Hospital, Nagoya; Tatsuro Joh and Masao Tomonaga, Japanese Red Cross Nagasaki Genbaku Hospital; Shinichiro Yoshida, Nagasaki Medical Center; Kunihiro Tsukasaki, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Science, Nagasaki; Naokuni Uike, National Kyushu Cancer Center; Toshihiro..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Fujiwara","sequence":"additional","affiliation":[{"name":"Takashi Ishida, Hiroshi Inagaki, and Ryuzo Ueda, Nagoya City University Graduate School of Medical Sciences; Kazuhito Yamamoto, Aichi Cancer Center; Michinori Ogura, Nagoya Daini Red Cross Hospital, Nagoya; Tatsuro Joh and Masao Tomonaga, Japanese Red Cross Nagasaki Genbaku Hospital; Shinichiro Yoshida, Nagasaki Medical Center; Kunihiro Tsukasaki, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Science, Nagasaki; Naokuni Uike, National Kyushu Cancer Center; Toshihiro..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Ishitsuka","sequence":"additional","affiliation":[{"name":"Takashi Ishida, Hiroshi Inagaki, and Ryuzo Ueda, Nagoya City University Graduate School of Medical Sciences; Kazuhito Yamamoto, Aichi Cancer Center; Michinori Ogura, Nagoya Daini Red Cross Hospital, Nagoya; Tatsuro Joh and Masao Tomonaga, Japanese Red Cross Nagasaki Genbaku Hospital; Shinichiro Yoshida, Nagasaki Medical Center; Kunihiro Tsukasaki, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Science, Nagasaki; Naokuni Uike, National Kyushu Cancer Center; Toshihiro..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Inagaki","sequence":"additional","affiliation":[{"name":"Takashi Ishida, Hiroshi Inagaki, and Ryuzo Ueda, Nagoya City University Graduate School of Medical Sciences; Kazuhito Yamamoto, Aichi Cancer Center; Michinori Ogura, Nagoya Daini Red Cross Hospital, Nagoya; Tatsuro Joh and Masao Tomonaga, Japanese Red Cross Nagasaki Genbaku Hospital; Shinichiro Yoshida, Nagasaki Medical Center; Kunihiro Tsukasaki, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Science, Nagasaki; Naokuni Uike, National Kyushu Cancer Center; Toshihiro..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michinori","family":"Ogura","sequence":"additional","affiliation":[{"name":"Takashi Ishida, Hiroshi Inagaki, and Ryuzo Ueda, Nagoya City University Graduate School of Medical Sciences; Kazuhito Yamamoto, Aichi Cancer Center; Michinori Ogura, Nagoya Daini Red Cross Hospital, Nagoya; Tatsuro Joh and Masao Tomonaga, Japanese Red Cross Nagasaki Genbaku Hospital; Shinichiro Yoshida, Nagasaki Medical Center; Kunihiro Tsukasaki, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Science, Nagasaki; Naokuni Uike, National Kyushu Cancer Center; Toshihiro..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiro","family":"Akinaga","sequence":"additional","affiliation":[{"name":"Takashi Ishida, Hiroshi Inagaki, and Ryuzo Ueda, Nagoya City University Graduate School of Medical Sciences; Kazuhito Yamamoto, Aichi Cancer Center; Michinori Ogura, Nagoya Daini Red Cross Hospital, Nagoya; Tatsuro Joh and Masao Tomonaga, Japanese Red Cross Nagasaki Genbaku Hospital; Shinichiro Yoshida, Nagasaki Medical Center; Kunihiro Tsukasaki, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Science, Nagasaki; Naokuni Uike, National Kyushu Cancer Center; Toshihiro..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Tomonaga","sequence":"additional","affiliation":[{"name":"Takashi Ishida, Hiroshi Inagaki, and Ryuzo Ueda, Nagoya City University Graduate School of Medical Sciences; Kazuhito Yamamoto, Aichi Cancer Center; Michinori Ogura, Nagoya Daini Red Cross Hospital, Nagoya; Tatsuro Joh and Masao Tomonaga, Japanese Red Cross Nagasaki Genbaku Hospital; Shinichiro Yoshida, Nagasaki Medical Center; Kunihiro Tsukasaki, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Science, Nagasaki; Naokuni Uike, National Kyushu Cancer Center; Toshihiro..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensei","family":"Tobinai","sequence":"additional","affiliation":[{"name":"Takashi Ishida, Hiroshi Inagaki, and Ryuzo Ueda, Nagoya City University Graduate School of Medical Sciences; Kazuhito Yamamoto, Aichi Cancer Center; Michinori Ogura, Nagoya Daini Red Cross Hospital, Nagoya; Tatsuro Joh and Masao Tomonaga, Japanese Red Cross Nagasaki Genbaku Hospital; Shinichiro Yoshida, Nagasaki Medical Center; Kunihiro Tsukasaki, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Science, Nagasaki; Naokuni Uike, National Kyushu Cancer Center; Toshihiro..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuzo","family":"Ueda","sequence":"additional","affiliation":[{"name":"Takashi Ishida, Hiroshi Inagaki, and Ryuzo Ueda, Nagoya City University Graduate School of Medical Sciences; Kazuhito Yamamoto, Aichi Cancer Center; Michinori Ogura, Nagoya Daini Red Cross Hospital, Nagoya; Tatsuro Joh and Masao Tomonaga, Japanese Red Cross Nagasaki Genbaku Hospital; Shinichiro Yoshida, Nagasaki Medical Center; Kunihiro Tsukasaki, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Science, Nagasaki; Naokuni Uike, National Kyushu Cancer Center; Toshihiro..."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1991.tb08051.x"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.16.4558"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V50.3.481.bloodjournal503481"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.18.2428"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.11.9958"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1702731"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-10-247510"},{"key":"B8","first-page":"3625","volume":"9","author":"Ishida T","year":"2003","journal-title":"Clin Cancer Res"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.5.1505"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M210665200"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-2697"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-0983"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0900699"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.25.3575"},{"key":"B15","first-page":"1250","volume":"14","author":"Tobinai K","year":"2009","journal-title":"Oncology (Williston Park)"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/BF02986621"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1994.394"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.28.0669"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199506293322603"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3109\/10428190109057927"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.03166.x"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-2263"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/11.1.81"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1084\/jem.194.6.847"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxh165"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2006.00307.x"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2010.01767.x"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.04999.x"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.22536"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1003466"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1084\/jem.192.2.303"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/nri1806"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23086"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/23495"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-0371"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-09-310342"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V116.21.962.962"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-0261"}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO.2011.37.3472","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T23:16:17Z","timestamp":1653520577000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JCO.2011.37.3472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,10]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,3,10]]}},"alternative-id":["10.1200\/JCO.2011.37.3472"],"URL":"https:\/\/doi.org\/10.1200\/jco.2011.37.3472","relation":{},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,10]]}}}